KEWALRAMANI RESHMA (CEO & President) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 1/26/2026ACC: 0000875320-26-000018
DirectorOfficer· CEO & President
Since Feb 2026
+38.86K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
38.86K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+26.97K
Price / share
—
Trade value
—
% of position
23.3%
1/22/2026
115.97K→142.94K
Common Stock
Direct
Shares
+11.88K
Price / share
—
Trade value
—
% of position
8.3%
1/22/2026
142.94K→154.82K
Total
Net shares
+38.86K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | A · Award | +26.97K | — | — | 23.3% | 115.97K | 142.94K |
| Common Stock Direct | 1/22/2026 | A · Award | +11.88K | — | — | 8.3% | 142.94K | 154.82K |
| Total | +38.86K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported